Josep M Sierra Mariana Camoez Fe Tubau Oriol Gasch Miquel Pujol Rogelio Martin M Angeles Domínguez
10.1371/journal.pone.0059215
PLoS One
2013;8(3):e59215.
CC BY
https://pubmed.ncbi.nlm.nih.gov/23554998/
Acetamides / therapeutic use Anti-Bacterial Agents / therapeutic use Bacterial Proteins / metabolism Methicillin-Resistant Staphylococcus aureus / drug effects Methicillin-Resistant Staphylococcus aureus / isolation & purification Oxazolidinones / therapeutic use Staphylococcal Infections / drug therapy
Acetamides / therapeutic use Anti-Bacterial Agents / therapeutic use Bacterial Proteins / metabolism Methicillin-Resistant Staphylococcus aureus / drug effects Methicillin-Resistant Staphylococcus aureus / isolation & purification Oxazolidinones / therapeutic use Staphylococcal Infections / drug therapy Case Reports Research Support, Non-U.S. Gov't Aged Drug Resistance, Multiple, Bacterial Hospitals Humans Linezolid Male Methicillin / therapeutic use Methicillin-Resistant Staphylococcus aureus / metabolism Microbial Sensitivity Tests Spain Staphylococcal Infections / microbiology Acetamides Anti-Bacterial Agents Bacterial Proteins CFR protein, Staphylococcus aureus Oxazolidinones Linezolid Methicillin
PMC3598648
23554998
Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy
2013